Research Article

[Retracted] Serum Exosomal MicroRNAs Predict Acute Respiratory Distress Syndrome Events in Patients with Severe Community-Acquired Pneumonia

Table 1

Baseline characteristics and outcome parameters in SCAP patients with and without ARDS.

VariablesARDS (n=24)Non-ARDS (n=29)P value

Age (yrs)59.63 ± 15.8662.47 ± 12.100.078
Sex ( men)18 (76%)19 (67%)0.209
APACHE II score16.08 ± 9.4112.83 ± 9.010.205
SOFA score5.67 ± 3.554.45 ± 3.340.208
PSI 97.79 ± 28.3895.31 ± 21.390.031
PaO2/FIO2 ratio170.26 ± 105.49226.47 ± 88.860.04
Co-morbidities
(i) Pulmonary embolism, n (%)2 (8%)4 (14%)0.541
(ii) Hypertension, n (%)10 (42%)10 (34%)0.6
(iii) Diabetes mellitus, n (%)6 (25%)6 (21%)0.715
(iv) COPD, n (%)3 (13%)9 (31%)0.113
(v) Cardiovascular/cerebrovascular diseases, n (%)6 (25%)6 (21%)0.715
Complication
(i) Sepsis7 (29%)7 (24%)0.686
(ii) AKI3 (13%)4 (14%)0.893
Platelet count (×109/L)181.5 ± 77.61197.9 ± 108.90.539
28-day mortality12 (50%)10 (34%)0.262
Microbiological species
(i) Streptococcus pneumoniae6 (25%)6 (21%)0.715
(ii) Haemophilus influenzae1 (4%)2 (7%)0.676
(iii) Legionella pneumophila0 (0%)1 (3%)0.368
(iv) Mycoplasma pneumoniae1 (4%)4 (14%)0.241
(v) Other9 (39%)6 (21%)0.151
(vi) unknown7 (29%)5 (17%)0.311
Invasive mechanical ventilation, n ()16 (67%)13 (45%)0.116
PEEP (cmH2O)7.04 ± 4.734.86 ± 0.8330.092
Hospital stay, days20.17 ± 8.2516.41 ± 8.420.109
Laboratory parameters
(i) CRP (mg/dl)90.27 ± 72.1575.3 ± 58.430.408
(ii) Procalcitonin1.75 ± 4.291.55 ± 3.760.858
(iii) Ang2 (ng/ml)7.55 ± 1.675.08 ± 0.650.149
(iv) IL-6 (pg/ml)62.04 ± 13.3913.61 ± 2.010.002
(v) IL-10 (pg/ml)10.66 ± 1.0426.1 ± 7.530.07
(vi) vWF (% of control)449.64 ± 118.45266.64 ± 18.240.001

Data were presented as n (%), mean ± standard deviation. P value <0.05 was considered as statistically significant.
APACHE II, Acute Physiology and Chronic Health Evaluation II score; CRP, C-reactive protein; PSI, pneumonia severity index; SOFA score, Sequential Organ Failure Assessment score; CRP, C-reactive protein; PSI, pneumonia severity index; PEEP, positive end-expiratory pressure; Ang-2, angiopoietin 2; vWF, von Willebrand factor.